Quadria Capital Annual report 2020 (final)

Progress & Performance Update : Strand Life Sciences
ESG Annual Report
Increasing Accessibility of Healthcare
As one of the leading specialized diagnostics company in the country, Strand has been making it easier for our
patients to access critical diagnostic testing over 40 cities.. Strand conducted over 1682,408 in 2020. In addition,
the company provides over 10 proprietary next generation sequencing tests to patients.
Outlook for 2021
Learning and Development
Strand employs rigorous quality systems, including training and competency of professional and technical staff
and internal auditing. In 2020, the company spent over 375 hours in training across various themes ranging
from LEAP scientific session, POSH Policy training, lab safety trainings, fire safety training, session on
performance management, power of habits, crucial conversations, induction for new employees and mental
wellness sessions.
Strand plans further integration of ESG focus within its processes and strengthening ESG implementation
for sustained performance of the Company. One of the initiatives identified for 2021 is implementing
an employee engagement software. Strand will continue its value creation journey by making available
critical and specialized testing at an affordable price to improve overall well-being and health
outcomes.
Governance Impact
The company strengthened its governance mechanism by institutionalizing an Executive Committee,
committee of the Board of Directors, which meets on a monthly basis to discuss operational and compliance
matters. The company has strengthened the process and protocols on Governance through an Audit
committee, Nomination & Remuneration committee and appointed an internal auditor to improve the
effectiveness of the company’s internal control and its corporate governance and accounting processes. The
last Board meeting for the Company was held in December, 2020.
27 28